UnitedHealth Group (UNH) Research Report — Score, Intrinsic Value, Peer Rankings

UnitedHealth Group (UNH)Healthcare / Healthcare Plans

StockRover

Stock Report | September 27, 2026

$376.59 $1.58(0.42%)as of Friday's close

52‑wk Range

$255.97

$461.62

Cap ($M USD) $338,025

P/E 24.2

EPS (1Y)-32.7%

Dividend$9.28

Last Filing06/30/26

Sales ($M)450,129

Fwd. P/E 16.7

Sales (1Y)6.5%

Fwd. Yield 2.5%

Next Earnings10/13/26

UNH has underperformed the S&P 500 by -8.0% in the past year.

UNH has underperformed its sector by -17.7% in the past year.

The Healthcare sector has outperformed the market by 9.7% in the past year.

ANALYST CONSENSUS

Strong Buy

The consensus rating has worsened a little since last month when it was also Strong Buy.

Strong Buy

Buy

Hold

Sell

Strong Sell

Strong BuyBuyHoldSellStrong Sell

QUANTITATIVE SCORES

Fair Value

$387.92

Margin of Safety

The Margin of Safety is the difference between a company's Fair Value and the current price. See more on page 8.

3 warnings

Details on Page 8

Value Score

Value Score: Our value score looks at EV/EBITDA, P/E, P/S, P/TB (Price/Tangible Book) and EPS Predictability. P/S and P/TB are compared within a sector. Other metrics are compared across all stocks

Quality Score

Quality Score: Our quality score compares profitability and balance sheet metrics to find high quality companies using ROIC, Net Margin, Gross Margin, Interest Coverage, and Debt / Equity metrics.

Growth Score

Growth Score: Our growth score looks at the 5 year history and the forward estimates for EBITDA, Sales, and EPS growth, ranking the best companies across all stocks.

Sentiment Score

Sentiment Score: Our sentiment score finds stocks in favor by analyzing Short Interest, returns in key periods over the last year, Price vs. 52-wk High, Days Since 52-wk High and MACD signals.

BUSINESS SUMMARY

UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2025. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to affiliates and third parties.

Employees 390,000Homepage www.unitedhealthgroup.comHeadquarters Eden Prairie, MN

UnitedHealth Group (UNH)Healthcare / Healthcare Plans

StockRover

Stock Report | September 27, 2026

VALUATION SUMMARY

	UNH	Industry	S&P 500
Value Score	87	85	69
Price / Earnings	24.2	26.7	27.0
Price / Sales	0.8	0.4	3.7
Price / Free Cash Flow	14.5	10.7	36.3
Price / Book	3.5	2.3	5.9
Price / Tangible Book	-	-	374.0
EV / EBITDA	15.2	14.4	19.7
EPS Predict. Pctl.	82	68	71
Piotroski F Score	6	6	6

5‑Year P/E Range	10.0 41.4
5‑Year P/B Range	2.3 7.2
5‑Year P/S Range	0.5 1.8

GROWTH SUMMARY

	UNH	Industry	S&P 500
Growth Score	80	68	78
Sales Growth
Sales Growth Next Year	2.9%	2.9%	23.2%
Sales 1‑Year Chg (%)	6.5%	4.8%	22.6%
Sales 3‑Year Avg (%)	8.9%	8.7%	14.8%
Sales 5‑Year Avg (%)	10.6%	10.3%	13.4%
EPS Growth
Next Yr. Growth Est.	13.8%	14.1%	33.7%
EPS 1‑Year Chg (%)	-32.7%	-25.9%	37.3%
EPS 3‑Year Avg (%)	-11.4%	-12.4%	18.3%
EPS 5‑Year Avg (%)	0.5%	-0.6%	15.3%

PEERS ANALYSIS SUMMARY

Ticker

Cell value has been edited

Company

Cell value has been edited

Cap ($M USD)

Cell value has been edited

P/E

Cell value has been edited

Fwd. Yield

Cell value has been edited

1M Return

Cell value has been edited

1Y Return

Cell value has been edited

Margin of Safety

Cell value has been edited

Value Score

Cell value has been edited

Growth Score

Cell value has been edited

Quality Score

Cell value has been edited

LLY

Eli Lilly

$1,054,885

39.7

0.6%

-4.1%

66.7%

-8%

100

JNJ

Johnson & Johnson

$653,612

31.4

2.0%

-0.7%

56.0%

-2%

ABBV

AbbVie

$467,119

74.7

2.6%

-0.5%

24.7%

-3%

UNH

UnitedHealth Group

$338,025

24.2

2.5%

-4.5%

11.9%

CVS

CVS Health

$113,994

23.5

3.0%

-4.1%

23.3%

39%

MCK

McKesson

$101,041

23.2

0.4%

-4.1%

18.1%

-5%

ELV

Elevance Health

$85,899

17.5

1.7%

-0.3%

27.6%

14%

Cigna Group

$71,876

11.2

2.3%

-2.1%

11%

HUM

Humana

$47,783

37.6

0.9%

2.1%

58.7%

-12%

CNC

Centene

$30,538

-4.9%

79.8%

-14%

MOH

Molina Healthcare

$9,962

500+

-4.4%

0.8%

OSCR

Oscar Health

$9,135

23.0

-4.3%

63.6%

31%

UnitedHealth Group (UNH)Healthcare / Healthcare Plans

StockRover

Stock Report | September 27, 2026

PROFITABILITY SUMMARY

	UNH	Industry	S&P 500
Quality Score	68	58	75
Gross Margin	19.5%	10.9%	32.8%
Operating Margin	4.8%	2.6%	16.9%
Net Margin	3.1%	1.5%	13.8%
Return on Assets	4.8%	3.8%	15.4%
Return on Equity	14.3%	12.0%	40.2%
ROIC	10.0%	8.0%	32.2%

RETURNS SUMMARY

	UNH	Industry	S&P 500
Sentiment Score	71	50	62
5‑Day Return	-0.1%	-0.6%	1.2%
1‑Month Return	-4.5%	-4.0%	1.1%
YTD Return	16.3%	15.6%	14.0%
1‑Year Return	11.9%	14.9%	18.5%
3‑Year Return	-21.4%	-14.0%	85.1%
5‑Year Return	1.3%	2.2%	85.9%
Beta 1‑Year	0.42	0.33	1.00

UnitedHealth Group RETURNS SUMMARY chart

DIVIDEND

	UNH	Industry
Forward Dividend Yield	2.5%	2.2%
Payout Ratio	57.5%	46.0%
TTM Yield	2.4%	-
Fwd. Div. Per Share	$9.28	$6.36
Div. 1Y Chg (%)	5.0%	-
Div. 3Y Avg (%)	7.3%	-
Div. 5Y Avg (%)	9.9%	-
Cons. Growth Years	10+	-
Div. Coverage Ratio	1.7	1.7

DEBT & EQUITY

Current Ratio	0.8
Quick Ratio	0.8
Price	$376.59
Net Cash Per Share	-$46.32
Equity Per Share	$108.78
Debt / Equity	0.7
Solvency Ratio	10%
Interest Coverage	5.5
Short % of Float	1.9%
Altman Z‑Score	3.1

ANALYST REVISIONS

Current Quarter EPS
# Up Last 30 days	4.00
# Down Last 30 days	1.00
Mean Estimate	4.15
% Change (30 Days)	0.75%

Next Quarter EPS
# Up Last 30 days	1.00
# Down Last 30 days	4.00
Mean Estimate	2.10
% Change (30 Days)	-1.57%

MEAN ESTIMATE TREND

	Cur Qtr	Next Qtr	Cur Year	Next Year
Latest	$4.15	$2.10	$19.87	$22.61
30 Days Ago	$4.12	$2.14	$19.81	$22.44
90 Days Ago	$3.73	$2.59	$18.39	$20.93
% Change (90 Days)	11.2%	-18.9%	8.0%	8.0%

UnitedHealth Group (UNH)Healthcare / Healthcare Plans

StockRover

Stock Report | September 27, 2026

EARNINGS SURPRISES

Earnings surprise is the difference between a company's announced earnings and the average analyst estimated value. Surprises typically causes the stock price to jump and are often followed by more of the same surprise type.

Surprise Summary (Last 12 Quarters)

Surprise Type	Amount	Percent
Positive Quarters (> 2%)	7	58.3%
Negative Quarters (< 2%)	1	8.3%
In-Line Quarters (within 2%)	4	33.3%

Surprise Detail (Last 6 Quarters)

Surprise Type	Announce Date	Period End Date	Actual EPS	Est. EPS	Surprise (%)
Positive	08/04/26	06/30/26	$6.38	$4.94	29.1%
Positive	04/21/26	03/31/26	$7.23	$6.46	11.9%
In-Line	01/15/26	12/31/25	$2.11	$2.09	1.0%
Positive	10/21/25	09/30/25	$2.92	$2.75	6.2%
Negative	07/29/25	06/30/25	$4.08	$4.84	-15.7%
In-Line	04/17/25	-	$7.20	$7.27	-1.0%

RISK

	UNH	Industry	S&P 500
Best Monthly Return (5Y)	35.2%	30.0%	9.6%
Worst Monthly Return (5Y)	-24.7%	-20.4%	-9.6%
Beta 1‑Year	0.42	0.33	1.00
Volatility 1‑Year	0.35	0.29	0.13
Volatility 1Y Pctl.	35	-	-
Max Drawdown 1‑Year	-29.0%	-28.8%	-8.8%
Max Drawdown 3‑Year	-61.4%	-55.2%	-18.7%
Max Drawdown 5‑Year	-61.4%	-58.2%	-24.6%

SEASONALITY

Seasonal Performance vs the S&P 500

5-YEAR RELATIVE PERFORMANCE VS S&P 500

Relative to the S&P 500 baseline, UNH has underperformed the S&P 500 by -85.1% in the past 5 Years.

UNH has underperformed its sector by -32.3% in the past 5 Years.

The Healthcare sector has underperformed the market by -52.8% in the past 5 Years.

UnitedHealth Group 5-YEAR RELATIVE PERFORMANCE VS S&P 500 chart

UnitedHealth Group (UNH)Healthcare / Healthcare Plans

StockRover

Stock Report | September 27, 2026

Overall Rating
vs. Peers

Ratings scores are relative to industry groups. They compare key metrics to rank stocks vs. their competitors.
For example, higher growth than peers will score high even when the absolute growth is below the market average.

Growth vs Peers

Ticker

Cell value has been edited

Company

Cell value has been edited

Growth Rating vs. Peers

Cell value has been edited

Sales QoQ Chg.

Cell value has been edited

Eps QoQ Chg.

Cell value has been edited

Sales Growth Next Y.

Cell value has been edited

Sales 1Y Chg (%)

Cell value has been edited

Sales 3Y Avg (%)

Cell value has been edited

Sales 5Y Avg (%)

Cell value has been edited

Cigna Group

6.7%

10.2%

4.2%

7.7%

14.9%

11.2%

CNC

Centene

9.9%

-1.6%

13.9%

11.1%

11.4%

CVS

CVS Health

7.3%

188.8%

2.9%

7.4%

7.0%

8.3%

UNH

UnitedHealth Group

0.4%

61.5%

2.9%

6.5%

8.9%

10.6%

ELV

Elevance Health

1.4%

-13.1%

1.9%

6.3%

6.7%

9.2%

Valuation vs Peers

Ticker

Cell value has been edited

Company

Cell value has been edited

Valuation Rating vs. Peers

Cell value has been edited

P/E

Cell value has been edited

Fwd. P/E

Cell value has been edited

PEG Trailing

Cell value has been edited

P/S

Cell value has been edited

P/B

Cell value has been edited

5Y P/E Range

Cell value has been edited

Cigna Group

11.2

8.1

8.3

0.3

1.7

8.5

31.0

CVS

CVS Health

23.5

10.5

0.3

1.4

7.8

220.7

ELV

Elevance Health

17.5

13.4

3.0

0.4

1.9

10.7

27.4

CNC

Centene

11.6

0.2

1.4

3.7

UNH

UnitedHealth Group

24.2

16.7

46.4

0.8

3.5

10.0

41.4

Efficiency vs Peers

Ticker

Cell value has been edited

Company

Cell value has been edited

Efficiency Rating vs. Peers

Cell value has been edited

Gross Margin

Cell value has been edited

Operating Margin

Cell value has been edited

Net Margin

Cell value has been edited

5Y ROE Range

Cell value has been edited

5Y ROA Range

Cell value has been edited

UNH

UnitedHealth Group

19.5%

4.8%

3.1%

12.3%

26.0%

4.1%

9.0%

Cigna Group

8.8%

3.2%

2.3%

5.7%

15.2%

0.3%

4.5%

ELV

Elevance Health

0.0%

2.5%

11.1%

17.5%

4.0%

6.5%

CVS

CVS Health

14.2%

3.4%

1.2%

0.6%

11.1%

0.2%

3.6%

CNC

Centene

7.8%

0.8%

-2.5%

-33.4%

12.5%

-8.0%

4.1%

Financial Strength vs Peers

Ticker

Cell value has been edited

Company

Cell value has been edited

Financial Str. Rating vs. Peers

Cell value has been edited

Debt / Equity

Cell value has been edited

Interest Coverage

Cell value has been edited

Quick Ratio

Cell value has been edited

Intangibles %

Cell value has been edited

Solvency Ratio

Cell value has been edited

Short % of Float

Cell value has been edited

UNH

UnitedHealth Group

0.7

5.5

0.8

42.1%

10%

1.9%

ELV

Elevance Health

0.7

5.1

31.1%

21%

2.8%

CNC

Centene

0.7

-6.1

1.1

18.1%

-7%

3.1%

CVS

CVS Health

1.0

2.9

0.7

43.4%

1.4%

Cigna Group

0.8

7.1

0.7

46.1%

11%

2.7%

Dividends vs Peers

Ticker

Cell value has been edited

Company

Cell value has been edited

Dividends Rating vs. Peers

Cell value has been edited

Fwd. Yield

Cell value has been edited

TTM Yield

Cell value has been edited

Price

Cell value has been edited

Fwd. Div. Per Share

Cell value has been edited

Consecutive Div. Growth Years

Cell value has been edited

Payout Ratio

Cell value has been edited

Cigna Group

2.3%

$272.01

$6.24

25.3%

UNH

UnitedHealth Group

2.5%

2.4%

$376.59

$9.28

10+

57.5%

CVS

CVS Health

3.0%

$89.13

$2.66

69.5%

ELV

Elevance Health

1.7%

$396.09

$6.88

10+

30.3%

CNC

Centene

$61.82

Momentum vs Peers

Ticker

Cell value has been edited

Company

Cell value has been edited

Momentum Rating vs. Peers

Cell value has been edited

1M Return

Cell value has been edited

3M Return

Cell value has been edited

6M Return

Cell value has been edited

YTD Return

Cell value has been edited

1Y Return

Cell value has been edited

Beta 1Y

Cell value has been edited

Volatility 1Y

Cell value has been edited

Price vs 52‑wk High (%)

Cell value has been edited

ELV

Elevance Health

-0.3%

2.7%

34.9%

14.6%

27.6%

0.32

0.35

90.8%

CNC

Centene

-4.9%

-4.6%

88.9%

50.2%

79.8%

0.36

0.47

88.8%

UNH

UnitedHealth Group

-4.5%

-8.8%

40.9%

16.3%

11.9%

0.42

0.35

81.6%

CVS

CVS Health

-4.1%

-14.3%

25.3%

14.9%

23.3%

0.16

0.31

80.5%

Cigna Group

-2.1%

-3.0%

1.8%

0.5%

-2.1%

0.20

0.33

86.2%

UnitedHealth Group (UNH)Healthcare / Healthcare Plans

StockRover

Stock Report | September 27, 2026

DIVIDEND DETAIL

CALENDAR YEAR DIVIDEND HISTORY

Year

Cell value has been edited

Ex-Dividend Date

Cell value has been edited

Pay Date

Cell value has been edited

Text

Cell value has been edited

Amount

Cell value has been edited

2026 Dividends

$6.85

09/14/26

09/22/26

Regular

$2.32

06/15/26

06/23/26

Regular

$2.32

03/09/26

03/17/26

Regular

$2.21

2025 Dividends

$8.73

12/08/25

12/16/25

Regular

$2.21

09/15/25

09/23/25

Regular

$2.21

06/16/25

06/24/25

Regular

$2.21

03/10/25

03/18/25

Regular

$2.10

2024 Dividends

$8.18

12/09/24

12/17/24

Regular

$2.10

09/16/24

09/24/24

Regular

$2.10

06/17/24

06/25/24

Regular

$2.10

03/08/24

03/19/24

Regular

$1.88

2023 Dividends

$7.29

12/01/23

12/12/23

Regular

$1.88

09/08/23

09/19/23

Regular

$1.88

06/15/23

06/27/23

Regular

$1.88

03/10/23

03/21/23

Regular

$1.65

2022 Dividends

$6.40

12/02/22

12/13/22

Regular

$1.65

09/09/22

09/20/22

Regular

$1.65

06/16/22

06/28/22

Regular

$1.65

03/11/22

03/22/22

Regular

$1.45

UPCOMING DIVIDEND

Cell value has been edited

Ex-Dividend Date

09/14/26

Payment Date

09/22/26

Amount

$2.32

Type

Regular

DIVIDEND RATE

Cell value has been edited

Regular Dividend

$2.32

Forward Dividend Rate

$9.28

Forward Dividend Yield

2.5%

Trailing 12 Months Dividends

$9.06

Trailing 12 Months Yield

2.4%

STATISTICS

Cell value has been edited

Payout Ratio

57.4

Dividend Coverage Ratio

1.7

Consecutive Growth Years

10+

3 Year Growth Rate

7.3%

5 Year Growth Rate

9.9%

10 Year Growth Rate

14.0%

UnitedHealth Group (UNH)Healthcare / Healthcare Plans

StockRover

Stock Report | September 27, 2026

FINANCIAL STATEMENT SUMMARY

Income Statement

Revenue

Operating Income

Net income

Earnings per share diluted

Average shares diluted

P/E Ratio

Balance Sheet

Cash

Current assets

Net Property, Plant and Equipment

Working Capital

Net Debt

Stockholders' Equity

Cash Flow

Operating Cash Flow

Cap Ex

Free Cash Flow

Free Cash Flow per share

Profitability

Operating Margin

Return on Assets

Return on Equity

Return on Invested Capital

Dividends

Dividends Per Share

Dividend Yield

Dividend Growth

Dividend Coverage

287,597

324,162

371,622

400,278

447,567

450,129

9.9%

23,970

28,435

32,358

32,287

18,964

21,676

-2.1%

17,285

20,120

22,381

14,405

12,056

14,122

-4.2%

$18.08

$21.18

$23.86

$15.51

$13.23

$15.55

-3.1%

956

950

938

929

911

908

-1.1%

31.2

26.0

22.9

32.9

17.2

24.2

-5.2%

23,907

27,911

29,628

29,113

28,121

31,468

6.0%

61,758

69,069

78,437

85,779

90,582

86,860

7.5%

8,969

10,128

11,450

10,553

10,762

3.9%

-16,534

-20,168

-20,617

-17,990

-24,315

-24,960

-14.0%

22,096

29,712

32,909

47,791

50,268

41,860

14.4%

71,760

77,772

88,756

92,658

94,110

98,447

6.9%

22,343

26,206

29,068

24,204

19,697

27,017

4.1%

-2,454

-2,802

-3,386

-3,499

-3,622

-3,400

-9.8%

19,889

23,404

25,682

20,705

16,075

23,617

3.7%

$20.80

$24.64

$27.38

$22.29

$17.65

$26.01

4.8%

8.3%

8.8%

8.7%

8.1%

4.2%

4.8%

-10.9%

8.5%

9.0%

8.5%

5.3%

4.2%

4.8%

-11.5%

24.1%

25.9%

25.2%

15.5%

12.8%

14.3%

-10.4%

16.2%

17.0%

16.5%

10.5%

8.9%

10.0%

-9.7%

$5.60

$6.40

$7.29

$8.18

$8.73

$9.28

11.3%

1.2%

1.4%

1.7%

2.7%

2.5%

17.4%

14.3%

13.9%

12.2%

6.7%

9.0%

3.3x

3.4x

3.3x

1.9x

1.5x

1.7x

-12.5%

USD in Millions

Cell value has been edited

Chart

Cell value has been edited

2021

Cell value has been edited

2022

Cell value has been edited

2023

Cell value has been edited

2024

Cell value has been edited

2025

Cell value has been edited

TTM

Cell value has been edited

CAGR

Cell value has been edited

VALUATION & PROFITABILITY HISTORY

Date

Cell value has been edited

TTM

Cell value has been edited

1 Yr Ago

Cell value has been edited

2 Yrs. Ago

Cell value has been edited

3 Yrs. Ago

Cell value has been edited

4 Yrs. Ago

Cell value has been edited

Price / Earnings

24.2

14.5

35.2

23.3

28.1

Price / Cash Flow

12.7

11.0

55.9

11.7

21.3

Price / Book

3.5

3.3

6.1

5.9

6.6

Price / Tangible Book

Price / Sales

0.8

1.4

1.7

EV / EBITDA

15.2

10.6

21.0

14.8

17.7

Forward Dividend Yield

2.5%

2.6%

1.5%

1.3%

Shareholder Yield

2.8%

5.7%

2.3%

2.6%

2.5%

Gross Margin

19.5%

20.8%

23.5%

24.8%

24.0%

Net Margin

3.1%

5.0%

3.7%

6.1%

6.0%

Return on Assets

4.8%

7.4%

5.3%

8.5%

8.6%

Return on Equity

14.3%

22.5%

15.8%

25.6%

25.1%

ROIC

10.0%

14.1%

10.7%

16.4%

16.3%

UnitedHealth Group (UNH)Healthcare / Healthcare Plans

StockRover

Stock Report | September 27, 2026

WARNINGS

Name

Cell value has been edited

Severity

Cell value has been edited

Details

Cell value has been edited

High Goodwill

Medium

Goodwill %: 35.7%

Goodwill on a company's balance often results from over-paying to acquire other firms. A high percentage here can turn into impairment charges that weigh down future earnings for the company.

Declining EPS Growth

Low

EPS 1Y Chg (%): -32.7%; EPS 3Y Avg (%): -11.4%; EPS 5Y Avg (%): 0.5%

EPS growth has declined. Comparing EPS growth rates, the 1-year is less than the 3-year which is less than the 5-year. Be sure to understand the reasons as declining earnings growth puts pressure on the stock price.

Declining Sales Growth

Low

Sales 1Y Chg (%): 6.5%; Sales 3Y Avg (%): 8.9%; Sales 5Y Avg (%): 10.6%

Sales growth has declined. Comparing revenue growth rates, the 1-year is less than the 3-year which is less than the 5-year. Be sure to understand the reasons as declining sales growth puts pressure on the stock price.

REPORT TIPS

Metric Definitions

Metric descriptions are available at
stockrover.com/help/metrics/metric-overview

Quantitative Scores

Our scores analytics is to offer our concise analysis of a stock in powerful, but easy to digest format. Each of the composite score metrics are designed to use the best available accounting practices as well as source data from SEC filings. The scores are computed for a company vs. the market as a whole.

Fair Value

Fair value performs a forecasted discounted cash flow analysis of a company to determine the company's intrinsic value based on the expected future cash flows the company will produce. It basically determines what a company is worth based on how much cash flow it is expected to generate for you in the future, taking into account the time value of money and the predictability of those forecasted cash flows.

Peers

Peer ratings are computed from ranking companies in the same industry group. The selection of peers shown in the tables above are chosen from the same industry and closest proximity of revenue.

DISCLAIMER

Financial Statements and Historical Prices Provided by Morningstar. © 2026 Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Stock Rover and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely.

The information provided does not constitute investment advice, nor does it constitute a recommendation to buy or sell any security. Stock Rover LLC and its content providers are not responsible for any losses resulting from trading decisions arising from any use of this information. Past performance is no guarantee of future results.

The information provided is as of the date written and is subject to change without notice

Additional data provided by Zacks, Intrinio, Quandl, Yodlee, IEX Cloud

UnitedHealth Group (UNH) Research Report — September 27, 2026

ANALYST CONSENSUS

QUANTITATIVE SCORES

BUSINESS SUMMARY

VALUATION SUMMARY

GROWTH SUMMARY

PEERS ANALYSIS SUMMARY

PROFITABILITY SUMMARY

RETURNS SUMMARY

DIVIDEND

DEBT & EQUITY

ANALYST REVISIONS

MEAN ESTIMATE TREND

EARNINGS SURPRISES

RISK

SEASONALITY

5-YEAR RELATIVE PERFORMANCE VS S&P 500

Growth vs Peers

Valuation vs Peers

Efficiency vs Peers

Financial Strength vs Peers

Dividends vs Peers

Momentum vs Peers

DIVIDEND DETAIL

Returns

CALENDAR YEAR DIVIDEND HISTORY

UPCOMING DIVIDEND

DIVIDEND RATE

STATISTICS

FINANCIAL STATEMENT SUMMARY

VALUATION & PROFITABILITY HISTORY

WARNINGS

REPORT TIPS

DISCLAIMER